Overcoming chemoresistance in esophageal cancer with synergistic strategies
Esophageal cancer is a globally prevalent malignancy with poor clinical outcomes. Chemotherapy remains an effective strategy for esophageal cancer. However, its effectiveness is substantially limited by chemoresistance, which arises from both tumor cell adaptation and changes in the surrounding micr...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2026-06-01
|
| Серии: | Frontiers in Immunology |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1784325/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
